Bio-Rad Laboratories (BIO) Operating Margin (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Operating Margin data on file, last reported at 5.76% in Q1 2026.

• On a quarterly basis, Operating Margin rose 171.0% year-over-year to 5.76% in Q1 2026; TTM through Mar 2026 was 2.22%, a 754.0% decrease from a year earlier, with the FY2025 full-year figure at 1.83%, down 865.0% from the prior year.
• Operating Margin for Q1 2026 stood at 5.76%, up from 17.15% in the prior quarter.
• Over the last five years, Operating Margin for BIO reached as high as 20.91% in Q1 2022 and fell as low as 17.15% in Q4 2025.
• Historically, Operating Margin has averaged 10.35% across 5 years, with a median of 11.83% in 2025.
• Across the five-year window, Operating Margin surged 703 bps in 2022 and slumped 2589 bps in 2025, its largest moves.
• Year by year, Operating Margin stood at 16.25% in 2022, then decreased by 14 bps to 13.99% in 2023, then plunged by 38 bps to 8.73% in 2024, then plunged by 296 bps to 17.15% in 2025, then jumped by 134 bps to 5.76% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 5.76% in Q1 2026, 17.15% in Q4 2025, and 10.0% in Q3 2025.